Colombier Acquisition III Files for IPO

Dow Jones
Oct 18, 2025

By Kelly Cloonan

 

Colombier Acquisition III has filed for an initial public offering.

The special-purpose acquisition company said it will sell 26 million units at $10 apiece, according to a filing with the Securities and Exchange Commission on Friday.

The company has also granted underwriters a 45-day option to purchase up to an additional 3.9 million units to cover over-allotments. Roth Capital Partners is listed as the offering's underwriter.

The company additionally said that a sponsor has committed to purchase 150,000 private placement units at $10 per unit for an aggregate price of $1.5 million. The private placement is expected to close simultaneously with the closing of the IPO.

The company said it will receive gross proceeds of about $261.5 million from the offering, or about $300.5 million if the over-allotment option is exercised. Both figures include proceeds from the private placement.

The company intends to apply to have its units, Class A ordinary shares and warrants listed on the New York Stock Exchange under the symbols CLBR U, CLBR and CLBR WS, respectively.

The company intends to acquire businesses in industries including finance, entertainment, software, information services, telecommunications, industrial manufacturing and social media.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

October 17, 2025 16:41 ET (20:41 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10